Use of Galleria mellonella larvae to evaluate the in vivo

anti-fungal activity of [Ag2(mal)(phen)3] by Rowan, Raymond et al.
Use of Galleria mellonella larvae to evaluate the in vivo
anti-fungal activity of [Ag2(mal)(phen)3]
Raymond Rowan Æ Ciara Moran Æ Malachy McCann Æ
Kevin Kavanagh
Received: 21 August 2008 / Accepted: 26 November 2008 / Published online: 12 December 2008
 Springer Science+Business Media, LLC. 2008
Abstract Larvae of the insect Galleria mellonella
were employed to assess the in vivo antifungal
efficacy of ([Ag2(mal)(phen)3]), AgNO3 and 1,10-
phenanthroline. Larvae pre-inoculated with these
compounds were protected from a subsequent lethal
infection by the yeast Candida albicans while larvae
inoculated 1 and 4 h post-infection showed signifi-
cantly increased survival (P\ 0.01) compared to
control larvae. Administration of these compounds
resulted in an increase over 48 h in the density of
insect haemocytes (immune cells) but there was no
widespread activation of genes for antimicrobial
peptides. This work demonstrates that G. mellonella
larvae may be employed to ascertain the antifungal
efficacy of silver(I) compounds and offers a rapid and
effective means of assessing the in vivo activity of
inorganic antimicrobial compounds.
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Abbreviations
AMP Antimicrobial peptide(s)
apim 1-(3-Aminopropyl) imidazole
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Introduction
The yeast Candida albicans is an opportunistic
pathogen which is capable of inducing a wide range
of superficial and systemic infections in AIDS
patients (Fidel 2006), transplant recipients (Ascioglu
et al. 2002), cancer patients (Ascioglu et al. 2002) and
premature infants (Benjamin et al. 2004; Kaufman
2003). While conventional anti-fungal therapy relies
upon the use of polyenes and azole drugs to inhibit
the growth of the infecting yeast, rapid initiation of
anti-fungal therapy is necessary to control systemic
infection and has been shown to reduce mortality
(Morell et al. 2005).
The anti-fungal activities of silver(I) and 1,10-
phenanthroline have been known for many years and
the silver(I) ion is the active agent in many healthcare
products, such as silver-coated catheters (Rho et al.
2008; Khare et al. 2007), wound dressings (Totaro
and Rambaldini 2008; Adams et al. 1999) and burn-
treatment creams (Thomas and McCubbin 2003;
Holder et al. 2003).
Evidence for the potent anti-Candida activity of
silver(I) was provided by Desai and Herndon (1988)
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while the efficacy of topically applied silver(I) against
fungal pathogens of burned tissue has also been
demonstrated (Wright et al. 1999). Investigations into
the synthesis of silver(I)-containing complexes that
incorporate either 1,10-phenanthroline, salicylic acid,
malonic acid (malH2) or 1-3(-aminopropyl) imidazole
have generated silver(I) complexes with potent in vitro
anti-C. albicans activity (Rowan et al. 2006; McCann
et al. 2004; Coyle et al. 2003, 2004). In order to
establish the in vivo anti-fungal activity of selected
silver(I) compounds, it was decided to investigate
the interaction of one of these compounds, AgNO3
and 1,10-phenanthroline with C. albicans using the
Galleria mellonella model of infection.
Larvae of G. mellonella (the greater wax moth) can
be used to assess the pathogenicity ofmicrobial isolates
(Brennan et al. 2002) and the therapeutic potential of
anti-microbial drugs and have yield results that are
comparable to those obtained usingmammalianmodels
(Kavanagh and Reeves 2004). G. mellonella larvae
have also been proven to be able to distinguish between
pathogenic and non-pathogenic yeast isolates (Cotter
et al. 2000) while a strong correlation between the
virulence of C. albicans mutants in mice and in
G. mellonella larvae has been demonstrated (Brennan
et al. 2002). The insect immune response consists of a
cellular component which is composed of haemocytes
and a humoral element which involves the production
of anti-microbial peptides (AMPs). The numbers of
haemocytes circulating within the insect’s body cavity
increases in response to infection of G. mellonella by
C. albicans (Bergin et al. 2003). Antimicrobial peptides
are secreted into the haemolymph, diffuse to the site of
infection and attack portions of the microbial cell wall
(Ratcliffe 1985). The expression of the genes coding for
these AMPs is increased in response to infection with
C. albicans (Bergin et al. 2006). The aim of the work
presented here was to examine the in vivo antifungal
activity of a silver(I) complex ([Ag2(mal)(phen)3]),
AgNO3 and 1,10-phenanthroline and to ascertain their
effect on the immune response ofG. mellonella larvae.
Materials and methods
Culture conditions
Candida albicans ATCC 10231 was maintained on
YEPD agar [2% (w/v) bacteriological peptone
(Sigma), 2% (w/v) D-glucose (Sigma), 1% (w/v)
yeast extract (Sigma) and 2% (w/v) agar (Sigma)].
C. albicans 10231 was cultured in liquid minimal
medium (MM)[2% (w/v) D-glucose, 0.5% (w/v)
ammonium sulphate and 0.17% (w/v) yeast nitrogen
base without amino acids (Sigma)] at 30C and
200 rpm overnight. Anti-fungal susceptibility testing
was performed as described previously (Rowan et al.
2006). Susceptibility testing was carried out in
triplicate on three independent occasions and results
are presented as the mean ± standard deviation. The
MIC80 values represent the concentration of a com-
pound required to inhibit C. albicans cell growth by
80% in liquid culture.
Synthesis of silver(I) compounds
All chemicals were purchased from commercial
sources and were used without any further purification.
The [Ag2(mal)(phen)3] compound was synthesized as
described previously (McCann et al. 2000).
Inoculation of G. mellonella with C. albicans
Larvae of the sixth developmental stage of Galleria
mellonella were obtained from the Meal Worm
Company, (Sheffield, England). Larvae were main-
tained at 15C in wood shavings, stored in the dark
and used within 3 weeks of receipt. Larvae
(330 ± 20 mg) were inoculated in triplicate with
5 9 105 C. albicans cells as described (Cotter et al.
2000). All compounds were diluted in sterile PBS to
produce concentrations corresponding to twice their
MIC80 values (McCann et al. 2000). As negative
controls, un-infected larvae were inoculated with
20 ll of each compound and the toxicity of the
individual drug solutions was also monitored. Un-
infected larvae were also inoculated with 20 ll of
sterile PBS and the toxicity of 20 ll PBS was also
monitored.
Determination of haemocyte density
in G. mellonella larvae
Haemocyte density was assessed by bleeding three
larvae per treatment into a pre-chilled test tube
containing 4 mg phenylthiourea (Sigma–Aldrich) to
prevent melanisation. Haemocytes were diluted in
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PBS containing 0.37% (v/v) mercaptoethanol
(Sigma) and their density was ascertained by haem-
ocytometer count.
RNA extraction and RT-PCR analysis
Galleria larvae were inoculated with C. albicans and
exposed to the selected silver(I) compounds for the
indicated times. RNA was extracted as described
previously (Bergin et al. 2006). cDNA synthesis was
performed using isolated RNA (1 lg) with the
Superscript III first-strand synthesis system. RT-
PCR analysis of the expression of the genes coding
for the anti-microbial peptides gallerimycin (GLM),
galiomicin (GIM), transferrin (TFN) and inducible
metallo-proteinase inhibitor (IMPI) was performed as
described (Bergin et al. 2006).
Results
Anti-fungal activity of selected compounds
in vivo using G. mellonella
Larvae were inoculated with 5 9 105 C. albicans
cells and followed up 1 h later with either
[Ag2(mal)(phen)3], AgNO3 or 1,10-phenanthroline.
The most effective compound at providing protection
over the first 24 h was [Ag2(mal)(phen)3] followed by
1,10-phenanthroline and by the silver(I) salt AgNO3
(Fig. 1a). However, after 72 h, the most effective
compounds were 1,10-phenantroline followed by
AgNO3 (Fig. 1a). Un-infected larvae were also
inoculated with 20 ll of the compound solutions
and 100% survival was observed after 72 h (data not
presented).
In order to mimic a clinical response to infection
caused by C. albicans, larvae were inoculated with
C. albicans and subsequently administered the
selected anti-fungal compounds after 1 and 4 h
(Fig. 1b). The increased efficiency of a double dose
of AgNO3 was observed after 72 h of infection when
the survival of these larvae was significantly
increased compared to the survival of untreated
infected larvae (P\ 0.01). Double dosing of larvae
with [Ag2(mal)(phen)3] increased the survival of
infected larvae compared to the survival of control
larvae at 48 h. The 1,10 phenanthroline also
increased larval survival after 48 and 72 h.
Larvae were also pre-dosed with each compound
and followed up 1 h later by inoculation with
C. albicans. The results (Fig. 1c) demonstrated that
the survival of infected larvae prophylactically
treated with 1,10-phenanthroline prior to infection
with C. albicans was significantly increased (Fig. 1c).
Larvae treated with [Ag2(mal)(phen)3] demonstrated
an increase in survival after 24 h (Fig. 1c) with an
increase in survival was also evident after 72 h in
larvae that had been treated with 1-10-phenanthroline
and AgNO3 (Fig. 1c).
Prior exposure of Galleria mellonella to selected
compounds increases the number of circulating
hemocytes
In order to determine the efficacy of the compounds
in G. mellonella larvae, it was essential to establish
the effect that compounds had on the insect immune
response. Larvae were inoculated with the test
compounds and the density of circulating haemocytes
was ascertained at 1 and 4 h. After 1 h of exposure of
the larvae to 1,10-phenanthroline, the haemocyte
density had decreased, however, after 4 h the number
of haemocytes had significantly increased (Fig. 2). In
addition, the AgNO3 also increased the haemocyte
density following 4 h exposure (Fig. 2). Larvae
exposed to [Ag2(mal)(phen)3] demonstrated an
increase in haemocyte density after 4 h (Fig. 2).
These results demonstrated that administration of the
compounds results in an increase in the haemocyte
density of treated larvae. Hemocytes have an impor-
tant role in the insect immune response to infection
(Bergin et al. 2003) so this elevated number may
work in combination with the antifungal properties of
the compounds to arrest and kill C. albicans and thus
prevent larval death (Fig. 2).
Prior exposure of Galleria mellonella to selected
drugs increases the expression of genes coding
for selected anti-microbial peptides
The expression of the genes that code for the defensin
molecule galiomicin, a cysteine rich anti-fungal
peptide gallerimycin, the iron binding protein trans-
ferrin and the inducible metallo-proteinase inhibitor
was investigated following exposure of the larvae to
the compounds in order to establish whether the test
compounds primed this element of the insect immune
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response. The gene coding for GLM demonstrated the
most significant increase in expression in response to
the compounds (Fig. 3). Exposure of larvae to
[Ag2(mal)(phen)3] and 1,10-phenanthroline increased
the expression of GLM (Fig. 3). The expression of the
GIM gene was found not to be significantly increased
(P\ 0.01) in response to the compounds. Interest-
ingly, the expression of the TFN gene was found to be
significantly reduced (P\ 0.01) within larvae
exposed to AgNO3 while the expression of this gene
Fig. 1 Percentage survival
of G. mellonella larvae
inoculated with 5 9 105
C. albicans 10231 cells and
followed by inoculation
with compounds after a 1 h
or b 1 and 4 h or c 1 h prior
to inoculation. Larvae were
treated with 20 ll of drug
solutions with
concentrations
corresponding to twice their
in vitro anti-C. albicans
MIC80 values
(AgNO3 = 3.6 lM,
[Ag2(mal)(phen)3] = 4 lM
and 1,10-
phenanthroline = 6 lM).
Protection was deemed to
be significant at
P\ 0.01(*) relative to the
sterile water control
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was not found to be changed in response to exposure
to [Ag2(mal)(phen)3] or 1,10-phenanthroline (Fig. 3).
The expression of the IMPI within G. mellonella was
not found to be significantly altered (P\ 0.01) in
any of the larvae (Fig. 3). These results demonstrate
that of the four anti-microbial peptide genes inves-
tigated, only the expression of the gene coding for
gallerimycin was significantly increased following
administration of the compounds.
Discussion
Due to the strong similarities between the insect
immune response and the innate immune response of
mammals the use of insects as a model for studying
the interaction of microbial pathogens with the
immune response has increased (Kavanagh and
Reeves 2004). Insect models of microbial infections
have been employed to investigate the anti-microbial
properties of drugs (Mahajan-Miklos et al. 1999;
Bernall and Kimbrell 2000; Lionakis and Kontoy-
iannis 2005) and offer many advantages over the
use of mammals (Kavanagh and Reeves 2004).
G. mellonella has also been used to evaluate the
anti-fungal activity of amphotericin B, flucytosine
and fluconazole in an insect model of C. neoformans
infection (Mylonakis et al. 2005) while silkworms
have also been used to investigate the activity of
commonly used antibiotics including the antifungal
fluconazole (Hamamoto et al. 2004).
The results presented here demonstrate that admin-
istration of [Ag2(mal)(phen)3], 1,10 phenanthroline or
AgNO3 toG. mellonella larvae 1 h prior to, or 1 or 4 h
subsequent to infection with a lethal dose of
C. albicans can significantly increase the survival of
larvae (Fig. 1). Administration of the compounds did
lead to an alteration in the haemocyte density of
treated larvae (Fig. 2). These results demonstrate an
increase in haemocyte numbers which could contrib-
ute to the ability of the insect to kill C. albicans and
this may function in combination with the antifungal
properties of the compounds. Administration of the
test compounds resulted in the increased expression of
the gene for one AMP (gallerimycin) which indicates
that there is not widespread activation of this arm of
the insect immune response.
The data presented here demonstrate that larvae of
G. mellonella may be used to assess the in vivo
antifungal activity of [Ag2(mal)(phen)3], AgNO3 and
1,10-phenanthroline. The in vitro activity of these
compoundswas demonstrated previously (Rowan et al.
2006) and this is the first demonstration of the use of
insects for evaluating the in vivo antifungal activity of
these compounds. The use of insects for determining
the in vivo activity of antimicrobial compounds is now
well established (Hamamoto et al. 2004) and this work
demonstrates that theG. mellonella system can be used
for assessing the antimicrobial properties of inorganic
compounds. The use of G. mellonella offers many
advantages over the use of mice for this type of
screening including reduced cost, speed of results
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and the absence of ethical and legal considerations
(Kavanagh and Reeves 2004).
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